COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 523: Articles 5221-5230  | Next

Antibody escape, the risk of serotype formation, and rapid immune waning: modeling the implications of SARS-CoV-2 immune evasion
Albright, C., Van Egeren, D., Thakur, A., Chakravarty, A., White, L., Stoddard, M.
10.1101/2023.01.25.23285031 — Posted: 2023-01-26
LY6E protects mice from pathogenic effects of murine coronavirus and SARS-CoV-2
Mar, K. B., Van Dyke, M. C., Lopez, A. H., Eitson, J. L., Fan, W., Hanners, N. W., Evers, B. M., Shelton, J. M., Schoggins, J. W.
10.1101/2023.01.25.525551 — Posted: 2023-01-26
Rapid engineering of SARS-CoV-2 therapeutic antibodies to increase breadth of neutralization including XBB.1.5 and BQ.1.1
Entzminger, K. C., Fleming, J. K., Entzminger, P. D., Espinosa, L. Y., Samadi, A., Hiramoto, Y., Okumura, C., Maruyama, T.
10.1101/2023.01.25.525589 — Posted: 2023-01-26
Incident autoimmune diseases in association with a SARS-CoV-2 infection: A matched cohort study
Tesch, F., Ehm, F., Vivirito, A., Wende, D., Batram, M., Loser, F., Menzer, S., Jacob, J., Roessler, M., Seifert, M., Kind, B., Koenig, C., Schulte, C., Buschmann, T., Hertle, D., Ballesteros, P., Bassler, S., Bertele, B., Bitterer, T., Riederer, C., Sobik, F., Reitzle, L., Scheidt-Nave, C., Schmitt, J.
10.1101/2023.01.25.23285014 — Posted: 2023-01-26
HPV and HBV vaccine hesitancy, intention and uptake in the era of social media and COVID-19: A review
Vraga, E. K., Brady, S. S., Gansen, C., Khan, E. M., Bennis, S. L., Nones, M., Tang, R., Srivastava, J., Kulasingam, S.
10.1101/2023.01.25.23285015 — Posted: 2023-01-26
Estimations of SARS-CoV-2 endemic characteristics
Nesteruk, I.
10.1101/2023.01.24.23284980 — Posted: 2023-01-26
Acute tubulointerstitial nephritis with or without uveitis: a novel form of post-acute COVID-19 syndrome in children
Avramescu, M., Isnard, P., Temmam, S., Chevalier, A., Bastard, P., Attia, M., Berthaud, R., Fila, M., Dossier, C., Hogan, J., Ulinski, T., Leguevaques, D., Louillet, F., Martinez Casado, E., Halimi, J.-M., Cloarec, S., Zaloszyc, A., Faudeux, C., Rousset-Rouviere, C., Clave, S., Harambat, J., Rollot, E., Simon, T., Nallet-Amate, M., Ranchin, B., Bacchetta, J., Porcheret, F., Bernard, J., Ryckewaert, A., Jamet, A., Fourgeaud, J., Da Rocha, N., Perot, P., Kuperwasser, N., Bouazza, N., Rabant, M., Duong Van Huyen, J.-P., P Robert, M., Zuber, J., Casanova, J.-L., eloit, m., Sermet-Gaudelus, I., Boyer, O.
10.1101/2023.01.23.23284848 — Posted: 2023-01-26
Real-world effectiveness of molnupiravir, nirmatrelvir-ritonavir, and sotrovimab on preventing hospital admission among higher-risk patients with COVID-19 in Wales: a retrospective cohort study
Evans, A., Qi, C., Adebayo, L., Underwood, J., Coulson, J., Bailey, R., John, G., Cooper, A., Akbari, A., Lyons, R., Edwards, A.
10.1101/2023.01.24.23284916 — Posted: 2023-01-25
The impact of COVID-19 lockdown on a cohort of adults with recurrent major depressive disorder from Catalonia: a decentralized longitudinal study using remote measurement technology
Lavalle, R., Condominas, E., Haro, J. M., Gine-Vazquez, I., Bailon, R., Laporta, E., Garcia, E., Kontaxis, S., Riquelme, G., Lombardini, F., Preti, A., Penarrubia Maria, M. T., Coromina, M., Arranz, B., Vilella, E., Rubio Abadal, E., Matcham, F., Lamers, F., Hotopf, M., Penninx, B. W. J. H., Annas, P., Narayan, V., Simblett, S. K., Siddi, S.
10.1101/2023.01.24.23284906 — Posted: 2023-01-25
A role for Toll-like receptor 3 in lung vascular remodeling associated with SARS-CoV-2 infection
Farkas, D., Bogamuwa, S., Piper, B., Newcomb, G., Gunturu, P., Bednash, J. S., Londino, J. D., Elhance, A., Nho, R., Rosas Mejia, O., Yount, J. S., Horowitz, J. C., Goncharova, E. A., Mallampalli, R. K., Robinson, R. T., Farkas, L.
10.1101/2023.01.25.524586 — Posted: 2023-01-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).